Dexcom
| Company type | Public |
|---|---|
| |
| Founded | 1999 |
| Headquarters | San Diego, California, U.S. |
Key people | Kevin Sayer (chairman, president & CEO) |
| Products | Medical devices |
| Revenue | US$4.03 billion (2024) |
| US$600 million (2024) | |
| US$576 million (2024) | |
| Total assets | US$6.48 billion (2024) |
| Total equity | US$2.10 billion (2024) |
Number of employees | 10,300 (2024) |
| Website | dexcom |
| Footnotes / references | |
DexCom, Inc. is an American healthcare company that develops, manufactures, produces, and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California; and has manufacturing facilities in Mesa, Arizona; Batu Kawan, Malaysia; and Athenry, Ireland.